Back to Search Start Over

European League Against Rheumatism (EULAR) recommendations and EULAR/American College of Rheumatology criteria—documenting progress in lupus.

Authors :
Aringer, Martin
Tektonidou, Maria G
Boumpas, Dimitrios
Houssiau, Frédéric
Source :
Rheumatology; Jun2021, Vol. 60 Issue 6, p2976-2978, 3p
Publication Year :
2021

Abstract

The article reports on four papers published by the European League Against Rheumatism within a year on aspects of systemic lupus erythematosus (SLE). Topics mentioned include the use of direct oral anticoagulant rivaroxaban in patients with triple aPL positivity, incomplete understanding of SLE pathophysiology, and the first positive phase III trial on anifrolumab.

Subjects

Subjects :
RHEUMATOLOGY
RHEUMATISM

Details

Language :
English
ISSN :
14620324
Volume :
60
Issue :
6
Database :
Complementary Index
Journal :
Rheumatology
Publication Type :
Academic Journal
Accession number :
151011118
Full Text :
https://doi.org/10.1093/rheumatology/keaa672